Feng Chi Biotech Corp.
6744
Rank in Stocks
#30174
Feng Chi Biotech Corp., a company based in Taipei, Taiwan, specializes in... Feng Chi Biotech Corp., a company based in Taipei, Taiwan, specializes in offering a diverse range of diagnostic and scientific services. Their core activities encompass genetic screening for both pre-implantation and prenatal stages, comprehensive life science support, and early detection screening for newborns. Additionally, they perform microbiological assessments for the food and pharmaceutical sectors, alongside engaging in medical translational research. The company also acts as a supplier for various genetic testing technologies and products specifically tailored for the field of oncology.
Share Price
$0.39324952
Last synced: 2026-11-10
Market Cap
$5.78M
Change (1 day)
2.38%
Change (1 year)
-35.17%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Feng Chi Biotech Corp. (6744)
Category
Healthcare
Operating Margin for Feng Chi Biotech Corp. (6744)
Operating Margin as of November 2026 TTM: 4.55%
According to Feng Chi Biotech Corp.'s latest financial reports, its current operating margin (TTM) is 4.55%. At the end of 2025 the company had an operating margin of 7.81%.
Operating Margin history for Feng Chi Biotech Corp. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 4.55% | -41.74% |
| 2025 | 7.81% | -17.09% |
| 2024 | 9.42% | -29.60% |
| 2023 | 13.38% | -4.36% |
| 2022 | 13.99% | -3.38% |
| 2021 | 14.48% | -9.39% |
| 2020 | 15.98% | 38.59% |
| 2019 | 11.53% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -91.52% |
US
|
|
| -149.01% | -132.75% |
US
|
|
| 25.57% | -94.38% |
AU
|
|
| 31.23% | -93.14% |
BE
|
|
| 29.35% | -93.55% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Feng Chi Biotech Corp.'s operating margin
What is Feng Chi Biotech Corp.'s operating margin?
Feng Chi Biotech Corp.'s operating margin is 4.55%, as of Nov 2026.
What was Feng Chi Biotech Corp.'s operating margin in 2025?
In 2025, Feng Chi Biotech Corp.'s operating margin was 7.81%, compared with 9.42% in 2024.
How has Feng Chi Biotech Corp.'s operating margin changed since 2020?
From 2020 to 2025, Feng Chi Biotech Corp.'s operating margin was highest in 2020 (15.98%) and lowest in 2025 (7.81%).
How does Feng Chi Biotech Corp.'s operating margin compare with similar companies?
Feng Chi Biotech Corp.'s operating margin (4.55%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.